Millions of people receive primaquine against sexual plasmodia responsible for malaria transmission. These gametocytes cause no symptoms and do not threaten the host, but they infect mosquitoes and threaten the community. Primaquine causes hemolysis in the small minority of patients with glucose-6-phosphate dehydrogenase deficiency (G6PDd). Clinical studies in the 1950s demonstrated gametocytocidal primaquine to be safe without G6PDd screening. However, the evaluated G6PDd variant, African A-...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Consideration of ethics in primaquine therapy against malaria transmission.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record